Jing Marantz
Director Técnico/Científico/I+D en SCHOLAR ROCK HOLDING CORPORATION .
Fortuna: 1 M $ al 30/04/2024
Cargos activos de Jing Marantz
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
ARCTURUS THERAPEUTICS HOLDINGS INC. | Director/Miembro de la Junta | 07/12/2021 | - |
Independent Dir/Board Member | 07/12/2021 | - | |
SCHOLAR ROCK HOLDING CORPORATION | Director Técnico/Científico/I+D | 09/11/2022 | - |
Arcturus Therapeutics Ltd.
Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics Ltd. engages in the provision of RNA medicines, which focuses on liver and respiratory diseases. Its RNA medicines include mRNA; siRNA, miRNA, and ASO;, CRISPR, TALEN, and meganucleases; and Replicon RNA and DNA. The company was founded by Joseph Payne in March 2013 and is headquartered in San Diego, CA. | Director/Miembro de la Junta | - | - |
Arcturus Therapeutics, Inc.
Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics, Inc. engages in the development of technology and therapeutics for rare diseases. It specializes in the application of application of ribonucleic acid technologies for the treatment of disease. The company was founded by Joseph E. Payne and Padmanabh Chivukula in 2013 and is headquartered in San Diego, CA. | Director/Miembro de la Junta | - | - |
Historial de carrera de Jing Marantz
Antiguos cargos conocidos de Jing Marantz.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
KRYSTAL BIOTECH, INC. | Director/Miembro de la Junta | 04/01/2021 | 18/01/2022 |
Independent Dir/Board Member | 04/01/2021 | 18/01/2022 | |
Corporate Officer/Principal | 18/01/2022 | 01/08/2022 | |
ACCELERON PHARMA INC. | Director Técnico/Científico/I+D | 01/10/2020 | 01/11/2021 |
ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 20/06/2018 | 01/09/2020 |
ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/08/2016 | 01/06/2018 |
ARIAD PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | 01/02/2012 | - |
Formación de Jing Marantz.
Tongji Medical College of Huazhong University of Sci & Tech | Doctorate Degree |
Medical University of South Carolina | Doctorate Degree |
University of California, Berkeley | Masters Business Admin |
Estadísticas
Internacional
Estados Unidos | 12 |
China | 2 |
Operativa
Director/Board Member | 4 |
Chief Tech/Sci/R&D Officer | 3 |
Corporate Officer/Principal | 3 |
Sectorial
Health Technology | 10 |
Consumer Services | 4 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 4 |
---|---|
ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
KRYSTAL BIOTECH, INC. | Health Technology |
ARCTURUS THERAPEUTICS HOLDINGS INC. | Health Technology |
SCHOLAR ROCK HOLDING CORPORATION | Health Technology |
Empresas privadas | 5 |
---|---|
ARIAD Pharmaceuticals, Inc.
ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
Acceleron Pharma, Inc.
Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis in June 2003 and is headquartered in Cambridge, MA. | Health Technology |
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Arcturus Therapeutics Ltd.
Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics Ltd. engages in the provision of RNA medicines, which focuses on liver and respiratory diseases. Its RNA medicines include mRNA; siRNA, miRNA, and ASO;, CRISPR, TALEN, and meganucleases; and Replicon RNA and DNA. The company was founded by Joseph Payne in March 2013 and is headquartered in San Diego, CA. | Health Technology |
Arcturus Therapeutics, Inc.
Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics, Inc. engages in the development of technology and therapeutics for rare diseases. It specializes in the application of application of ribonucleic acid technologies for the treatment of disease. The company was founded by Joseph E. Payne and Padmanabh Chivukula in 2013 and is headquartered in San Diego, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Jing Marantz
- Experiencia